Daily as of 3 Nov 16:00 ET
- Price
- between the two $8.82 vs 50 $10.50 / 200 $8.30
- Projection
- 💀Death cross estimated in 20 to 30 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 8 May 2026 · projected 16 bars out
CADL | Candel TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$8.82
+$0.70 (+8.62%)
Candel Therapeutics (CADL) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since May 2026, but the two have been closing on each other and a death cross is projected within 30 bars. Price sits between the 50 and the 200 on the daily, above both on the weekly and below both on the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $8.33 vs 50 $7.77 / 200 $5.12
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 16:00 ET
- Price
- below both $8.82 vs 50 $9.05 / 200 $10.35
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 19 Oct 2026 · projected 29 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 19 Oct 2026 | 💀Death | 4-hour | 29 bars out | Not tested |
| 8 May 2026 | 🟨Golden moderate | daily | 16 bars out | Not tested |
| 29 Apr 2026 | 🟨Golden | 4-hour | 25 bars out | Not tested |
| 20 Mar 2026 | 💀Death moderate | daily | 24 bars out | Not tested |
| 5 Mar 2026 | 💀Death | 4-hour | 18 bars out | Not tested |
About CADL
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$10.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandsmall